Inify Laboratories Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—5

Registered number: 15997568

		31 December 2025		31 December 2024
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		4,986,462		-

			4,986,462		-
CURRENT ASSETS
Stocks	5	45,522		-
Debtors	6	312,377		100
Cash at bank and in hand		202,518		-

		560,417		100
Creditors: Amounts Falling Due Within One Year	7	(1,645,617 )		-

NET CURRENT ASSETS (LIABILITIES)			(1,085,200 )		100

TOTAL ASSETS LESS CURRENT LIABILITIES			3,901,262		100

Creditors: Amounts Falling Due After More Than One Year	8		(4,638,251 )		-

NET (LIABILITIES)/ASSETS			(736,989 )		100

CAPITAL AND RESERVES
Called up share capital	10		100		100
Profit and Loss Account			(737,089 )		-

SHAREHOLDERS' FUNDS			(736,989)		100

Page 1

Page 2

Inify Laboratories Limited

Balance Sheet (continued)

As At 31 December 2025

For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Ann-Charlotte Linderoth

Director

26/05/2026

The notes on pages 3 to 5 form part of these financial statements.

1. General Information

Inify Laboratories Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15997568 . The registered office is 191c Nebula, Park Drive, Milton Park, Oxfordshire, OX14 4SE.

The presentation currency of the financial statements is Pound Sterling (£)

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Going Concern Disclosure

The financial statements have been prepared on a going concern basis. In making this assessment, the directors have considered the company’s financial position, including its net liabilities at the reporting date, and its reliance on continued financial support from its parent undertaking.

The directors have received confirmation from the parent undertaking that it will provide financial support sufficient to enable the company to meet its obligations as they fall due for a period of at least 12 months from the date of approval of these financial statements. Accordingly, the directors consider it appropriate to prepare the financial statements on a going concern basis

2.3. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Assets under construction are capitalised at cost and are not depreciated until they are available for their intended use. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Leasehold	10% SL
Plant & Machinery	10% SL
Fixtures & Fittings	10% SL
Computer Equipment	20% SL

2.5. Stocks and Work in Progress

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

2.6. Financial Instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities, such as cash, trade and other accounts receivables and payable and loans to and from third parties, including related parties.

2.7. Foreign Currencies

Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 4 (2024: NIL)

Page 3

Page 4

Inify Laboratories Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2025

4. Tangible Assets

	Improvements to Property	Plant & Machinery	Fixtures & Fittings	Computer Equipment	Total
	£	£	£	£	£
Cost
As at 1 January 2025	-	-	-	-	-
Additions	4,046,431	740,701	19,919	191,370	4,998,421

As at 31 December 2025	4,046,431	740,701	19,919	191,370	4,998,421

Depreciation
As at 1 January 2025	-	-	-	-	-
Provided during the period	11,959	-	-	-	11,959

As at 31 December 2025	11,959	-	-	-	11,959

Net Book Value
As at 31 December 2025	4,034,472	740,701	19,919	191,370	4,986,462

As at 1 January 2025	-	-	-	-	-

During the year, the company incurred significant expenditure on the construction and fit-out of its laboratory premises. At 31 December 2025, the premises were still under construction and had not yet been occupied or brought into operational use.

Accordingly, the related costs have been capitalised as tangible fixed assets under construction and no depreciation has been charged on these assets during the year. The company occupied the premises and commenced operations in January 2026, at which point depreciation will begin.

5. Stocks

	31 December 2025	31 December 2024
	£	£
Stock	45,522	-

6. Debtors

	31 December 2025	31 December 2024
	£	£
Due within one year
Amounts owed by participating interests	-	100
Other debtors	312,377	-

	312,377	100

7. Creditors: Amounts Falling Due Within One Year

	31 December 2025	31 December 2024
	£	£
Trade creditors	1,354,471	-
Other creditors	275,621	-
Taxation and social security	15,525	-

	1,645,617	-

Page 4

Page 5

Inify Laboratories Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2025

8. Creditors: Amounts Falling Due After More Than One Year

	31 December 2025	31 December 2024
	£	£
Amounts owed to participating interests	4,409,488	-
Other creditors	228,763	-

	4,638,251	-

9. Provisions for Liabilities


	Other Provisions	Total
	£	£
Additions	228,763	228,763

Balance at 31 December 2025	228,763	228,763

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in the profit and loss in the period in which it arises.

10. Share Capital

	31 December 2025	31 December 2024
	£	£
Allotted, Called up and fully paid	100	100

11. Related Party Transactions

The company is a wholly owned subsidiary of Inify Laboratories AB, which is incorporated in Sweden and is the company’s ultimate controlling party.

During the year, the company received funding from Inify Laboratories AB to support the establishment of its operations, including the construction and fit-out of its laboratory premises.

At 31 December 2025, amounts owed to Inify Laboratories AB totalled £4,409,488 (2024: £100). These balances are unsecured, interest free and repayable on demand.

There were no other material related party transactions during the year

12. Ultimate Controlling Party

The company's ultimate controlling party is Inify Laboratories AB .

Page 5